Artemis Medicare Services Limited Stock Price Today (NSE: ARTEMISMED)

Artemis Medicare Services Limited

ARTEMISMEDHospital
₹306.35+₹3.35 (+1.11%)
Market Closed

Fundamental Score

...

Artemis Medicare Services Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Artemis Medicare Services Limited share price today is ₹306.35, up +1.11% on NSE/BSE as of 16 October 2026. Artemis Medicare Services Limited (ARTEMISMED) is a Small-cap company in the Hospital sector with a market capitalisation of ₹4.85K (Cr). The 52-week high for ARTEMISMED share price is ₹378.80 and the 52-week low is ₹203.35. At a P/E ratio of 42.61x, ARTEMISMED is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 11.69% and a debt-to-equity ratio of 0.24.

Artemis Medicare Services Limited Share Price Chart — NSE/BSE Historical Performance

Artemis Medicare Services Limited share price chart: -5.81% return over the past month. 52-week high ₹378.80, 52-week low ₹203.35.

Artemis Medicare Services Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
₹303.00₹310.00₹300.00₹306.351.44L (Cr)
₹302.85₹305.90₹300.55₹303.001.32L (Cr)
₹310.10₹313.10₹300.00₹301.752.32L (Cr)
₹310.00₹313.40₹303.85₹311.351.24L (Cr)
₹313.25₹317.60₹310.40₹311.451.62L (Cr)
₹308.25₹315.95₹308.25₹313.202.22L (Cr)
₹319.20₹319.20₹307.65₹308.453.40L (Cr)
₹316.00₹323.15₹316.00₹318.302.50L (Cr)
₹324.25₹324.95₹314.25₹318.354.29L (Cr)
₹339.20₹341.85₹322.35₹324.103.75L (Cr)

Artemis Medicare Services Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
₹342.80₹346.45₹300.00₹306.35-10.63%
₹317.45₹378.80₹306.60₹345.55+8.85%
₹304.80₹333.70₹299.00₹317.45+4.15%
₹263.65₹308.00₹258.40₹298.50+13.22%
₹276.30₹277.60₹253.20₹264.95-4.11%
₹244.13₹295.00₹243.01₹273.36+11.97%
₹207.50₹247.10₹207.50₹244.13+17.65%
₹234.12₹237.35₹203.35₹205.51-12.22%
₹245.00₹249.00₹210.06₹239.90-2.08%
₹271.95₹280.60₹221.00₹247.95-8.83%
₹287.90₹295.00₹261.55₹271.05-5.85%
₹247.56₹297.50₹240.35₹285.46+15.31%

Returns & Performance

Poor

Return on Equity (ROE)

11.69%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

14.15%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

15.33%

Average operating profit margin over 5 years

Dividend Yield

0.16%

Annual dividend as % of current share price

Artemis Medicare Services Limited Valuation Check

Good

Price to Earnings (P/E)

42.61x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

48.79x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

58.39%

% shares held by company founders/management

Good

FII Holding

12.22%

% shares held by foreign institutional investors

Poor

DII Holding

0.92%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

47.14%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

12.69%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

21.50%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

6.01%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

75.86%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.24x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

6.03x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

67.59 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Artemis Medicare Services Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ARTEMISMED across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Operating Margins (15.33%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Robust Profit Growth (47.14%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Consistent Growth Track Record (21.50% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (75.86% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.24)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (6.03x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Healthy Liquidity Position (Current Ratio: 1.74)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Strong Cash Generation (₹67.59 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (58.39%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Premium Valuation Risk (P/E: 42.61x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

High Price-to-Book Ratio (5.19x)

Observation: Trading at significant premium to book value.

Analysis: High P/B ratios may indicate overvaluation relative to asset base.

Artemis Medicare Services Limited vs Hospital Peers

Peer Comparison - Hospital

Compare Artemis Medicare Services Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
70.1/100
₹306
₹4849.70
42.6
Average
11.69%
Average
14.15%
Average
0.2
Excellent
75.86%
Excellent
21.50%
Excellent
0.16%
64.1/100
₹7890
₹113458.20
54.3
Average
21.95%
Excellent
19.28%
Good
0.6
Good
66.81%
Excellent
19.03%
Excellent
0.22%
55.5/100
₹846
₹82336.10
56.4
Average
14.33%
Average
13.43%
Average
0.3
Excellent
60.01%
Excellent
27.30%
Excellent
0.18%
50.6/100
₹737
₹55602.80
53.1
Average
11.08%
Average
12.83%
Average
0.3
Excellent
64.38%
Excellent
17.76%
Excellent
0.10%
65.7/100
₹1719
₹35137.83
42.8
Average
19.74%
Good
14.53%
Average
1.1
Average
155.30%
Excellent
25.05%
Excellent
0.22%
49.5/100
₹674
₹34940.10
109.1
Average
9.70%
Poor
11.35%
Average
0.2
Excellent
21.31%
Excellent
-11.61%
Poor
0.61%
57.9/100
₹1240
₹33327.48
59.9
Average
15.15%
Good
16.85%
Good
0.3
Excellent
80.71%
Excellent
24.97%
Excellent
0.04%
27.7/100
₹686
₹28795.20
134.4
Average
11.01%
Average
9.35%
Poor
1.4
Average
3.71%
Average
24.04%
Excellent
0.00%
57.3/100
₹466
₹14765.86
99.3
Average
6.84%
Poor
10.16%
Average
0.1
Excellent
34.42%
Excellent
34.58%
Excellent
0.00%
73/100
₹1249
₹12684.58
44.4
Average
17.86%
Good
18.10%
Good
0.0
Excellent
44.04%
Excellent
21.24%
Excellent
0.23%
66.1/100
₹992
₹9559.28
52.8
Average
9.98%
Poor
12.29%
Average
0.1
Excellent
57.39%
Excellent
41.18%
Excellent
0.00%

Artemis Medicare Services Limited Quarterly Performance

Latest quarterly metrics for ARTEMISMED — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

12.69%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

47.14%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

21.50%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

75.86%

Compounded annual net profit growth over 5 years

Artemis Medicare Services Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ARTEMISMED — calculated from daily price history

21RSI 14
Oversold — RSI 21

Selling pressure is heavy — potential reversal zone.

SMA 50
₹327
▼ Price below SMA 50 — Short-term bearish
SMA 200
₹272
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
1082K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Artemis Medicare Services Limited Financial Statements

Annual income statement, balance sheet and cash flow for Artemis Medicare Services Limited (ARTEMISMED) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Artemis Medicare Services Limited

Loading latest quarterly results...

About ARTEMISMED (Artemis Medicare Services Limited)

Artemis Medicare Services Ltd is a prominent healthcare provider, weaving a tapestry of medical expertise across its network of hospitals. Each facility is a hub of advanced techno...logy and compassionate care, designed to cater to a diverse range of medical needs. From intricate surgical procedures to comprehensive medical management, Artemis hospitals are equipped with state-of-the-art diagnostic tools and treatment modalities. They foster an environment of healing, where patient well-being is at the heart of every endeavor. Artemis remains committed to fostering excellence and setting new standards in the delivery of healthcare services. Beyond the core medical and surgical interventions, Artemis Medicare Services Ltd emphasizes holistic patient care, recognizing the interconnectedness of physical and emotional well-being. Patients and their families benefit from a comprehensive suite of support services. This includes specialized programs like emotional support and counseling, nutritional guidance, and even childcare facilities, easing the burden on families during challenging times. Multilingual medical interpreters facilitate effective communication for international patients, ensuring a seamless and comfortable experience. Artemis proactively promotes a patient-centric approach by actively involving patients and their families in the decision-making process through advisory councils. The Artemis Medicare Services Ltd commitment to excellence is further demonstrated through cutting-edge initiatives like telemedicine and patient portals. These innovations improve accessibility to healthcare. Patients can effortlessly schedule appointments, access their medical records, and communicate with healthcare professionals remotely. The focus on continuous innovation allows Artemis to extend its reach and cater to a growing number of patients across India and internationally. Artemis Medicare strives to provide accessible, affordable, and high-quality healthcare to all.

Company Details

Symbol:ARTEMISMED
Industry:Hospital
Sector:Hospital

Key Leadership

Dr. Devlina Chakravarty DMRD, DNB, M.D., Radiology
CEO, MD & Executive Director
Mr. Sanjiv Kumar Kothari
Chief Financial Officer
Ms. Poonam Makkar
Company Secretary & Compliance Officer

ARTEMISMED Share Price: Frequently Asked Questions

What is the current share price of Artemis Medicare Services Limited?

Artemis Medicare Services Limited (ARTEMISMED) trades at ₹306.35 on NSE and BSE. Market cap ₹4.85K (Cr). Educational data only.

What is the P/E ratio of Artemis Medicare Services Limited?

Artemis Medicare Services Limited has a P/E of 42.61x vs industry average 48.79x.

What is the Bull Run score for Artemis Medicare Services Limited?

Artemis Medicare Services Limited has a Bull Run score of 70.1/100 based on 25+ financial parameters.

Does Artemis Medicare Services Limited pay dividends?

Artemis Medicare Services Limited has a dividend yield of 0.16%. Past dividends don't guarantee future payments.

What is the ROE of Artemis Medicare Services Limited?

Artemis Medicare Services Limited has ROE of 11.69%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Artemis Medicare Services Limited?

Artemis Medicare Services Limited has debt-to-equity of 0.24.

Is Artemis Medicare Services Limited a good investment?

Bull Run gives Artemis Medicare Services Limited a score of 70.1/100. This is not investment advice — consult a SEBI-registered advisor.